Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9677
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDonnan, Geoffrey Aen
dc.date.accessioned2015-05-15T22:51:36Z
dc.date.available2015-05-15T22:51:36Z
dc.date.issued2004-01-01en
dc.identifier.citationThe Lancet. Neurology; 3(1): 9en
dc.identifier.govdoc14693098en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9677en
dc.language.isoenen
dc.subject.other3',5'-Cyclic-AMP Phosphodiesterases.geneticsen
dc.subject.otherAntihypertensive Agents.therapeutic useen
dc.subject.otherBlood Pressure.drug effectsen
dc.subject.otherClinical Trials as Topicen
dc.subject.otherCyclic Nucleotide Phosphodiesterases, Type 4en
dc.subject.otherFibrinolytic Agents.adverse effects.therapeutic useen
dc.subject.otherHumansen
dc.subject.otherRisk Factorsen
dc.subject.otherStroke.genetics.mortality.prevention & controlen
dc.subject.otherTreatment Outcomeen
dc.titleStroke: prediction, prevention, and outcome.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Lancet. Neurologyen
dc.identifier.affiliationNational Stroke Research Institute, Austin & Repatriation Medical Centre, University of Melbourne, Heidelberg West, Victoria, Australiaen
dc.description.pages9en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/14693098en
dc.type.austinJournal Articleen
local.name.researcherDonnan, Geoffrey A
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.